{
    "root": "bf2ebb2c-5958-4303-8161-049ca05c38d7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Carisoprodol",
    "value": "20230615",
    "ingredients": [
        {
            "name": "CARISOPRODOL",
            "code": "21925K482H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3419"
        },
        {
            "name": "ALGINIC ACID",
            "code": "8C3Z4148WZ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17548"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TRIBASIC CALCIUM PHOSPHATE",
            "code": "91D9GV0Z28",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "POTASSIUM SORBATE",
            "code": "1VPU26JZZ4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77868"
        }
    ],
    "indications": {
        "text": "carisoprodol tablets indicated relief discomfort associated acute , painful musculoskeletal conditions adults . limitation carisoprodol tablets used short periods ( two three weeks ) adequate evidence effectiveness prolonged established acute , painful musculoskeletal conditions generally short duration [ ( 2 ) ] .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended dose carisoprodol tablets 250 mg 350 mg three times day bedtime . recommended maximum duration carisoprodol tablets two three weeks .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "250 mg tablets : round , convex , white tablets , inscribed wp 5901 ; available bottles 100 ( ndc 51525-5901-1 ) .",
    "adverseReactions": "carisoprodol tablets contraindicated patients history acute intermittent porphyria hypersensitivity reaction carbamate meprobamate .",
    "indications_original": "Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.\n                  \n                     \n                        Limitation of Use\n                     \n                  \n                  Carisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see Dosage and Administration (2)].",
    "contraindications_original": "The recommended dose of carisoprodol tablets is 250 mg to 350 mg three times a day and at bedtime. The recommended maximum duration of carisoprodol tablets use is up to two or three weeks.",
    "warningsAndPrecautions_original": "250 mg Tablets: round, convex, white tablets, inscribed with WP 5901; available in bottles of 100 (NDC 51525-5901-1).",
    "adverseReactions_original": "Carisoprodol tablets are contraindicated in patients with a history of acute intermittent porphyria or a hypersensitivity reaction to a carbamate such as meprobamate.",
    "drug": [
        {
            "name": "Carisoprodol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3419"
        }
    ]
}